Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses
Oliver FitzGerald, Dafna D. Gladman, Philip J. Mease, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 9, pp. 1397-1407
Open Access | Times Cited: 5

Showing 5 citing articles:

Biomarker discovery in psoriatic disease
Darshini Ganatra, Vinod Chandran
Current Opinion in Rheumatology (2025)
Closed Access
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
Interventions in cytokine signaling: novel horizons for psoriasis treatment
Lisha Li, Jun Liu, Jiaye Lu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Successful Treatment of Erythroderma in a Psoriasis Patient, Developed After Anti‐IL‐17, Anti‐IL‐23 and Anti‐IL‐4/IL‐13 Treatment, With Deucravacitinib
Tugce Guel, Luka de Vos‐Hillebrand, Dagmar Wilsmann‐Theis, et al.
JEADV Clinical Practice (2025)
Open Access
Navigating Psoriatic Arthritis: Treatment Pathways and Patient-Specific Strategies for Improved Outcomes
Rubén Queiró, José Antonio Pinto-Tasende, Carlos Montilla
Drugs (2025)
Open Access
Page 1

Scroll to top